Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

AstraZeneca’s senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.

The coffee-machine-sized printer produces 3D humanlike tissue that should allow for better testing and development of ...

Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...

The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.

Insilico Medicine has completed a Series E round, raising $110m to progress the development of its pipeline of drugs and AI ...

Traditional methods of target identification in drug development often involve labor-intensive research and extensive experimental validation. This process can be time-consuming and fraught with ...

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

AI-powered tools like Merck’s Aiddison can accelerate drug identification and optimise design, cutting both costs and time to ...

The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...

Empire Discovery Institute (EDI), a leading non-profit drug discovery and development accelerator, is pleased to announce the appointment of Dr. Ronald Newbold as Chief Executive Officer (CEO).  Dr.